Citation: M. Quinkler et al., Clinical implications of glucocorticoid metabolism by 11 beta-hydroxysteroid dehydrogenases in target tissues, EUR J ENDOC, 144(2), 2001, pp. 87-97
Authors:
Quinkler, M
Johanssen, C
Bumke-Vogt, C
Oelkers, W
Bahr, V
Diederich, S
Citation: M. Quinkler et al., Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney, MOL C ENDOC, 171(1-2), 2001, pp. 21-24
Authors:
Diederich, S
Eckmanns, T
Exner, P
Al-Saadi, N
Bahr, V
Oelkers, W
Citation: S. Diederich et al., Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults, CLIN ENDOCR, 54(5), 2001, pp. 665-671
Authors:
Oelkers, W
Helmerhorst, FM
Wuttke, W
Heithecker, R
Citation: W. Oelkers et al., Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers, GYNECOL END, 14(3), 2000, pp. 204-213
Authors:
Diederich, S
Grossmann, C
Hanke, B
Quinkler, M
Herrmann, M
Bahr, V
Oelkers, W
Citation: S. Diederich et al., In the search for specific inhibitors of human 11 beta-hydroxysteroid-dehydrogenases (11 beta-HSDs): chenodeoxycholic acid selectively inhibits 11 beta-HSD-I, EUR J ENDOC, 142(2), 2000, pp. 200-207
Citation: H. Tuchelt et al., Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease, CLIN ENDOCR, 53(3), 2000, pp. 301-307
Citation: W. Oelkers et al., Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage, J CLIN END, 85(9), 2000, pp. 3266-3270
Citation: M. Quinkler et al., In vivo measurement of renal 11 beta-hydroxysteroid dehydrogenase type 2 activity, J CLIN END, 85(12), 2000, pp. 4921-4922
Authors:
Diederich, S
Quinkler, M
Burkhardt, P
Grossmann, C
Bahr, V
Oelkers, W
Citation: S. Diederich et al., 11 beta-Hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine, EUR J CL IN, 30, 2000, pp. 21-27
Authors:
Jordan, J
Toka, HR
Heusser, K
Toka, O
Shannon, JR
Tank, J
Diedrich, A
Stabroth, C
Stoffels, M
Naraghi, R
Oelkers, W
Schuster, H
Schobel, HP
Haller, H
Luft, FC
Citation: J. Jordan et al., Severely impaired baroreflex-buffering in patients with monogenic hypertension and neurovascular contact, CIRCULATION, 102(21), 2000, pp. 2611-2618
Authors:
Diederich, S
Quinkler, M
Hanke, B
Bahr, V
Oelkers, W
Citation: S. Diederich et al., 11 beta-hydroxysteroid dehydrogenases: key enzymes in the action of mineralocorticoids and glucocorticoids, DEUT MED WO, 124(3), 1999, pp. 51-55
Citation: W. Oelkers, Comment on comparison of the low dose short synacthen test (1 mu g), the conventional dose short synacthen test (250 mu g), and the insulin tolerancetest for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease, J CLIN END, 84(8), 1999, pp. 2973-2973
Authors:
Quinkler, M
Johanssen, S
Grossmann, C
Bahr, V
Muller, M
Oelkers, W
Diederich, S
Citation: M. Quinkler et al., Progesterone metabolism in the human kidney and inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites, J CLIN END, 84(11), 1999, pp. 4165-4171
Citation: W. Oelkers, The role of high- and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency, EUR J ENDOC, 139(6), 1998, pp. 567-570
Citation: W. Oelkers, Comparison of low- and high-dose corticotropin stimulation tests in patients with pituitary disease - Author's response, J CLIN END, 83(12), 1998, pp. 4532-4533